{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:42:25Z","timestamp":1790419345184,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":447,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jcin.2012.02.014","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T17:48:45Z","timestamp":1340041725000},"page":"626-635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Contemporary Incidence and Predictors of Stent Thrombosis and Other Major Adverse Cardiac Events in the Year After XIENCE V Implantation"],"prefix":"10.1016","volume":"5","author":[{"given":"Srihari S.","family":"Naidu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell W.","family":"Krucoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Rutledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian W.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Wilburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnankutty","family":"Sudhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Simonton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Hermiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2012.02.014_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacc.2007.10.028","article-title":"Off-label use of drug-coated stents: putting it in perspective","volume":"51","author":"Grines","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.02.014_bib2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-coated coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2012.02.014_bib3","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2005.02.086","article-title":"Late angiographic stent thrombosis (LAST) events with drug-coated stents","volume":"45","author":"Ong","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.02.014_bib4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-coated and bare metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2012.02.014_bib5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-coated coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2012.02.014_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.amjcard.2008.03.055","article-title":"Observations and outcomes of definite and probable drug-coated stent thrombosis seen at a single hospital in a four-year period","volume":"102","author":"Pinto Slottow","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2012.02.014_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents","volume":"52","author":"Joner","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.02.014_bib8","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.299.16.1903","article-title":"Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial","volume":"299","author":"Stone","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2012.02.014_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.108.803528","volume":"119","author":"Stone","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.02.014_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jacc.2011.02.022","article-title":"Randomized comparison of everolimus- and paclitaxel-eluting stents: 2 year follow up from the SPIRIT (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System) IV trial","volume":"58","author":"Stone","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.02.014_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jacc.2011.02.023","volume":"58","author":"Smits","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.02.014_bib12","article-title":"Abbott looks like the new stent king","author":"Goldstein","year":"2008","journal-title":"Wall Street Journal"},{"key":"10.1016\/j.jcin.2012.02.014_bib13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJMp068304","article-title":"Stent thrombosis redux\u2014the FDA perspective","volume":"356","author":"Farb","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2012.02.014_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhabitation and Patient Outcomes (PLATO) trial","volume":"124","author":"Mahaffey","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.02.014_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jacc.2005.11.025","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.02.014_bib16","first-page":"172","article-title":"Focused update of the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"2008","author":"King","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.02.014_bib17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ahj.2010.07.038","volume":"160","author":"Mauri","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2012.02.014_bib18","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2012.02.014_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomized trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2012.02.014_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2012.02.014_bib21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jcin.2009.10.001","article-title":"Safety and effectiveness of the endeavor zotarolimus-eluting stent in real-world clinical practice: 12 month data from the E-Five registry","volume":"2","author":"Lotan","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2012.02.014_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.104.532242","article-title":"Safety of coronary sirolimus-eluting stents in daily clinical practice: 1-year follow-up of the e-Cypher registry","volume":"113","author":"Urban","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.02.014_bib23","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jacc.2007.06.019","article-title":"Comparative clinical outcomes of paclitaxel and sirolimus-eluting stents: results from a large prospective multicenter registry\u2013STENT Group","volume":"50","author":"Simonton","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.02.014_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.amjcard.2007.02.051","article-title":"Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel eluting stents in an unselected population with coronary artery disease (REWARDS registry)","volume":"100","author":"Waksman","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2012.02.014_bib25","first-page":"433","article-title":"Usage patterns and 2-year outcomes with the TAXUS express stent: results of the ARRIVE 1 registry","volume":"72","author":"Lasala","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2012.02.014_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4244\/EIJV7I1A14","article-title":"Predictors of death or myocardial infarction, ischaemic-driven revascularization, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials","volume":"7","author":"Kereiakes","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2012.02.014_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jcin.2010.06.010","article-title":"Thrombosis of second-generation drug-eluting stents in real practice: results from the multicenter Spanish registry ESTROFA-2 (estudio Espanol sobre trombosis de stents Farmacoactivos de segunda generacion-2)","volume":"3","author":"De la Torre Hernandez","year":"2010","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2012.02.014_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ahj.2010.07.034","volume":"160","author":"Valgimigli","year":"2010","journal-title":"Am Heart J"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879812002981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879812002981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:58:17Z","timestamp":1761847097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879812002981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1936879812002981"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2012.02.014","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Incidence and Predictors of Stent Thrombosis and Other Major Adverse Cardiac Events in the Year After XIENCE V Implantation","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2012.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}